Medtronic initiated a global voluntary recall for certain lots of its Bravo calibration-free (CF) reflux testing system after reports of 184 serious injuries associated with a deployment control problem. Medtronic recalled the device “due to a risk of attachment and detachment issues related to the system’s delivery system,” a Medtronic spokesperson told MassDevice. “To ensure […]
Patient Monitoring
Philips and Exor extend relationship agreement, lift ownership cap to 22%
Royal Philips (NYSE: PHG, AEX: PHIA), a health technology company, and Exor today announced that they have agreed to update their long-term relationship agreement. It provides Exor — the investment arm of Italy’s wealthy Agnelli family – with the flexibility to increase its shareholding in Philips to up to 22% of the company’s issued ordinary […]
GE HealthCare could sell Patient Care Solutions biz as it reorganizes
GE HealthCare (Nasdaq: GEHC) recently announced that it is looking at strategic options, including a potential sale, of its $3-billion-a-year Patient Care Solutions business. Patient Care Solutions is involved with medtech for patient monitoring, diagnostic cardiology, maternal infant care and anesthesia. Its revenue has been slowly declining in recent years, bringing in $3.142 billion, $3.125 billion, […]
Philips announces partnerships to bring wearable data to its patient information ecosystem
Royal Philips (NYSE: PHG, AEX: PHIA) today announced new collaborations with Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree and smartQare, further expanding its open monitoring ecosystem. The collaborations will help health systems improve continuity and coordination of care by integrating wearable and out-of-hospital technologies into the Philips ecosystem, supporting connected patient monitoring from hospital […]
Diabetes Technology Innovations Special Report — 2026
Last year, MassDevice and Drug Delivery Business News rolled out the first edition of their Diabetes Technology Innovations Special Report. Now, we have the second edition available for free download, providing an in-depth overview of where the diabetes industry currently stands after another year of innovation and growth. The diabetes tech industry delivers some of the most advanced combinations of […]
Masimo names a new president
Masimo, a Danaher (NYSE:DHR) company, announced that it appointed Tim Benner as its president, effective Aug. 3, 2026. Benner’s appointment comes at the same time as Danaher’s naming of Julie Sawyer Montgomery as its new president and CEO. Sawyer Montgomery oversaw Danaher’s $10 billion acquisition of Masimo and led the unit in its early days as […]
Danaher promotes new CEO from within
Danaher (NYSE:DHR) announced today that it appointed Julie Sawyer Montgomery as its new president and CEO. Sawyer Montgomery’s appointment goes into effect on Oct. 1, 2026. On that date, Rainer Blair intends to retire, serving as a senior advisor until March 31, 2027, to ensure a seamless transition. Since she joined the company in 2017, […]
Ceribell earns Medicare win for brain monitoring tech
Ceribell (Nasdaq:CBLL) announced today that CMS granted a New Technology Add-on Payment (NTAP) for its Delirium Monitor System. Sunnyvale, California-based Ceribell said the NTAP covers up to $2,171 per eligible Medicare patient case utilizing the technology. The NTAP goes into effect on Oct. 1, 2026. Ceribell’s system utilizes point-of-care electroencephalography (EEG), analyzing segments and notifying […]
Dexcom Q2 results beat expectations, lead to increased sales outlook
Dexcom (Nasdaq:DXCM) today reported second-quarter results that came in ahead of the consensus Wall Street forecast. Shares of DXCM rose 2% to $76.02 apiece after the market closed today. The San Diego-based continuous glucose monitor (CGM) maker reported profits of $249.1 million. That equals 64¢ per share on sales of $1.31 billion for the three […]
Masimo gets FDA clearance for pediatric patient state index platform
Danaher’s (NYSE:DHR) Masimo unit announced today that it received FDA 510(k) clearance for its Patient State Index (PSi) for pediatric patients. Irvine, California-based Masimo — which became a part of Danaher through a $10 billion acquisition last month — said the PSi represents the first-and-only sedation score specifically designed for the unique physiology of the pediatric […]
FDA selects Dexcom for new digital health device pilot
The FDA announced today that it selected Dexcom (Nasdaq:DXCM) as the first manufacturer for a new digital health pilot. Dexcom joins the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot. It intends to provide a device for use in delivering care expected to be covered by the Centers for Medicare & Medicaid Services […]
